New industrial orders in Germany increased month on month in December 2021

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

China's April CPI Rises Moderately to 1.2%; PPI Surges Significantly Driven by International Commodities and Computing Power Demand

On May 11, the National Bureau of Statistics of China released data showing that in April 2026, the national Consumer Price Index (CPI) rose by 1.2% year-on-year, an increase of 0.2 percentage points from the previous month, with the month-on-month figure turning from a decline to a rise. The moderate recovery of the CPI was primarily driven by the dual impact of surging energy prices and an explosion in travel demand during holidays.

You're Invited: China's Innovation, Up Close

​China is no longer just a manufacturing hub or a consumer market to watch from a distance. It has become the world's most dynamic innovaton laboratory where AI applications scale faster, humanoid robots roll off production lines at mass-market prices, smart factories rewrite the rules of manufacturing, and internet platforms evolve their business models quicker than anywhere else.

EqualOcean Releases the 'EqualOcean 2025 GoGlobal Service Enablers TOP 50'

EqualOcean released the "EqualOcean 2025 GoGlobal Service Enablers TOP 50", selecting 50 representative companies across different segments and sectors, to record and pay tribute to their contributions in advancing the globalization of Chinese enterprises.

EqualOcean Releases the 'EqualOcean 2025 GoGlobal Investment Firms TOP 20'

In the global expansion of Chinese companies, the role of investment institutions is becoming increasingly crucial: they are not just capital providers but also strategic shapers. Through capital allocation, resource networking, and strategic guidance, capital is continuously propelling Chinese companies overseas, helping them globalize their R&D, production capacity, and channels.